Organization | Swedish Red Cross University College

Swedish Red Cross University College Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2016

NCT04324346

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Now

Alternative names

Swedish Red Cross University College | The Swedish Red Cross University College

Active Ingredients

Drugs in Other Trials (5)

cyclophosphamide (cytoxan) (1 trial)

docetaxel (taxotere) (1 trial)

epirubicin (ellence) (1 trial)

fluorouracil (efudex) (1 trial)

paclitaxel (taxol) (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 1
# of Trial APIs: 5